ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, that is in a clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in a clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm.
|HQ||Waltham, MA, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (12-Nov-2021)
Closing stock price (12-Nov-2021)
|USD||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021|
Depreciation and Amortization
Cash From Operating Activities
|Company Name||Date||Deal Size|
|ImmunoGen BioPharma (Ireland) Limited|
|ImmunoGen Europe Limited|
|ImmunoGen Securities Corp.|
ImmunoGen revenue breakdown by business segment: 48.2% from License and Milestone Fees, 51.8% from Non-Cash Royalty Revenue and 0.0% from Other
ImmunoGen has 1.01k Twitter Followers. The number of followers has increased 0.7% month over month and increased 2.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was ImmunoGen founded?
ImmunoGen was founded in 1981.
Who are ImmunoGen key executives?
ImmunoGen's key executives are Mark Enyedy, Audrey Bergan and Susan Altschuller.
How many employees does ImmunoGen have?
ImmunoGen has 79 employees.
What is ImmunoGen revenue?
Latest ImmunoGen annual revenue is $132.3 m.
What is ImmunoGen revenue per employee?
Latest ImmunoGen revenue per employee is $1.7 m.
Who are ImmunoGen competitors?
Competitors of ImmunoGen include Puma Biotechnology, Ablynx and ADC Therapeutics.
Where is ImmunoGen headquarters?
ImmunoGen headquarters is located at 830 Winter St, Waltham.
Where are ImmunoGen offices?
ImmunoGen has an office in Waltham.
How many offices does ImmunoGen have?
ImmunoGen has 1 office.
Receive alerts for 300+ data fields across thousands of companies